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Sir,
The paper published in Br J Cancer (2002, 87: 181–186) on the
prognostic significance of molecular detection of melanoma cells
in melanoma patients under adjuvant interferon (Gogas et al,
2002) seems to be a continuation of the protocol we first applied in
the same research laboratory utilizing the same facilities, the same
methods and at least the same of some reagents (e.g. the ATTCC
SK-mel-28 cells) we used in an analogous work. The results of this
work have already been published (Konstantopoulos et al, 2001).
Gogas et al give no information pertaining to the status of
melanoma cells circulating in their patients before any surgical
manipulation (i.e. at first presentation). In our work, in 27 patients
tested, one was already positive before operation becoming
negative some time following operation. No data on that point
are given on the 418 cases studied by Gogas et al. This type of
information may permit further confirmation of a theory claiming
that surgery manipulations may cause forced release of melano-
cytes to blood circulation (Foss et al, 1995).
Gogas et al claim that no evidence for an interference of the so-
called ‘illegitimate transcription’ (Chelly et al, 1989) was shown in
normal samples; this is in agreement with our observations as well.
However, the possibility for the induction of transcription of
tyrosinase gene under interferon administration should not be
neglected. Interferon is a known inducer of expression of genes
coding for several molecules, the best example being several cell
surface markers. For a more reliable conclusion to be drawn, one
should also include subjects under similar doses of interferon for
other purposes as controls.
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